GINKGO BIOWORKS HOLDINGS, INC. Deferred Income Tax Expense (Benefit)
GINKGO BIOWORKS HOLDINGS, INC. (DNA) reported Deferred Income Tax Expense (Benefit) of -$1.36 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-02-26
- GINKGO BIOWORKS HOLDINGS, INC. deferred income tax expense (benefit) for fiscal 2025 was -$1.36M.
- GINKGO BIOWORKS HOLDINGS, INC. deferred income tax expense (benefit) for fiscal 2024 was -$936.00K.
- GINKGO BIOWORKS HOLDINGS, INC. deferred income tax expense (benefit) for fiscal 2023 was -$801.00K.
- GINKGO BIOWORKS HOLDINGS, INC. deferred income tax expense (benefit) for fiscal 2022 was -$14.61M.
| Period end | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$1.36M 10-K · filed 2026-02-26 |
| 2024-12-31 | -$936.00K 10-K · filed 2026-02-26 |
| 2023-12-31 | -$801.00K 10-K · filed 2026-02-26 |
| 2022-12-31 | -$14.61M 10-K · filed 2025-02-25 |
| 2021-12-31 | $0.00 10-K · filed 2024-02-29 |
| 2020-12-31 | $0.00 10-K · filed 2023-03-13 |